IDEXX Laboratories Other Cashflows From Investing Activities Over Time
| IDXX Stock | USD 428.59 11.35 2.72% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IDEXX Laboratories Performance and IDEXX Laboratories Correlation. IDEXX |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.107 | Earnings Share 10.35 | Revenue Per Share 46.447 | Quarterly Revenue Growth 0.066 | Return On Assets 0.2279 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Cashflows From Investing Activities Analysis
Compare IDEXX Laboratories and related stocks such as Waters, IQVIA Holdings, and Charles River Labora Other Cashflows From Investing Activities Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WAT | 1.2 M | (11.1 M) | (31 M) | 0.0 | (40.6 M) | (296.7 M) | (1.6 M) | (5 M) | (31.5 M) | (8.8 M) | (86.7 M) | (63.4 M) | 75.5 M | 67.9 M | 71.3 M |
| IQV | (140.5 M) | (140.5 M) | (140.5 M) | (140.5 M) | (91.9 M) | 11.4 M | 1.9 B | (823 M) | (328 M) | (586 M) | (178 M) | 5 M | (1.3 B) | (1.2 B) | (1.1 B) |
| CRL | 7 M | 5.4 M | (14.1 M) | (28.9 M) | (235.4 M) | (249.9 M) | (644.8 M) | 46.9 M | (825.7 M) | (519.6 M) | (419.7 M) | (1.2 B) | (129.5 M) | (116.5 M) | (122.3 M) |
| RVTY | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (22.9 M) | (7 M) | (8.1 M) | (8.5 M) |
| MTD | (3.1 M) | (33.8 M) | (1.7 M) | (2.5 M) | (5.1 M) | (18.2 M) | (107.5 M) | (89.9 M) | 3.8 M | (1.7 M) | (7.9 M) | (206.5 M) | (18.2 M) | (16.3 M) | (17.2 M) |
| A | 248 M | (2.2 B) | (19 M) | (1000 K) | (299 M) | (99 M) | (128 M) | (525 M) | (1.4 B) | 1000 K | (5 M) | (4 M) | (8 M) | (7.2 M) | (7.6 M) |
| TMO | 404.8 M | (4.9 B) | (1 B) | 11.5 M | (11.4 B) | (676.5 M) | (5.2 B) | (7.2 B) | (495 M) | (561 M) | (36 M) | (34 M) | 84 M | 75.6 M | 79.4 M |
| ILMN | 3.5 M | (60.1 M) | (89.4 M) | (439.3 M) | (51.3 M) | (43 M) | (43.2 M) | (83 M) | (115 M) | (49 M) | (222 M) | (1.1 B) | (305 M) | (274.5 M) | (288.2 M) |
| DHR | 52.6 M | 674.6 M | (1.4 B) | (959.6 M) | (2.8 B) | (14.2 B) | (4.9 B) | (361.9 M) | (2.2 B) | (361.6 M) | (20.1 B) | 37 M | (1.1 B) | (973.8 M) | (1 B) |
| TWST | (80 K) | (80 K) | (80 K) | (80 K) | (80 K) | (80 K) | 120 K | (434 K) | 21 K | (483 K) | (483 K) | (13.9 M) | (13.9 M) | (12.5 M) | (11.9 M) |
| ICLR | 648 K | (120.8 M) | (120.8 M) | (120.8 M) | (120.8 M) | (155 M) | (32.2 M) | (133.1 M) | 11.1 M | (111.4 M) | (10 M) | (10 M) | (10 M) | (9 M) | (9.4 M) |
IDEXX Laboratories and related stocks such as Waters, IQVIA Holdings, and Charles River Labora Other Cashflows From Investing Activities description
My Equities
My Current Equities and Potential Positions
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.